Screener
Tenet Healthcare THC Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Tenet Healthcare in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Tenet Healthcare’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:27 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0000070318-26-000037
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Current liabilities: | ||
| Current portion of long-term debt | $160 | $79 |
| Accounts payable | 1,371 | 1,360 |
| Accrued compensation and benefits | 864 | 858 |
| Professional and general liability reserves | 292 | 276 |
| Accrued interest payable | 113 | 81 |
| Income tax payable | 69 | — |
| Other current liabilities | 2,698 | 1,809 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Tenet Healthcare's accrued manufacturing costs?
- Tenet Healthcare (THC) reported accrued manufacturing costs of $864M in Q2 2026.
- How has Tenet Healthcare's accrued manufacturing costs changed year-over-year?
- Tenet Healthcare's accrued manufacturing costs increased by 9.0% year-over-year, from $793M to $864M.
- What is the long-term trend for Tenet Healthcare's accrued manufacturing costs?
- Over 4 years (2021 to 2025), Tenet Healthcare's accrued manufacturing costs has grown at a -1.1% compound annual growth rate (CAGR), from $896M to $858M.
Ask your AI about Tenet Healthcare's accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude